Cardinal Health (CAH) Stock Forecast & Price Target

$121.84 -1.58 (-1.28%)

(As of 11/22/2024 ET)

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 13 Analyst Ratings

Sell
1

Hold
5

Buy
7

Based on 13 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 1 has given a sell rating, 5 have given a hold rating, and 7 have given a buy rating for CAH.

Consensus Price Target

$123.00
0.95% Upside

According to the 13 analysts' twelve-month price targets for Cardinal Health, the average price target is $123.00. The highest price target for CAH is $139.00, while the lowest price target for CAH is $101.00. The average price target represents a forecasted upside of 0.95% from the current price of $121.84.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 11/26/23 to 11/25/24	1 Month Ago 10/27/23 to 10/26/24	3 Months Ago 8/28/23 to 8/27/24	1 Year Ago 11/26/22 to 11/26/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$123.00	$120.18	$118.45	$96.83
Forecasted Upside	0.95% Upside	8.38% Upside	7.61% Upside	-8.88% Downside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Hold

War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.46	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	0.95% Upside	27,073.48% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/4/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Boost Target	Hold ➝ Hold	$119.00 ➝ $124.00	+9.48%
11/4/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$119.00 ➝ $127.00	+12.13%
11/4/2024	UBS Group 4 of 5 stars		Boost Target	Buy ➝ Buy	$134.00 ➝ $139.00	+21.30%
11/4/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$110.00 ➝ $120.00	+1.99%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$117.00 ➝ $133.00	+14.53%
9/11/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$115.00 ➝ $125.00	+10.34%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
8/21/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$111.00 ➝ $123.00	+12.23%
8/15/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underweight ➝ Underweight	$95.00 ➝ $101.00	-6.48%
8/15/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $137.00	+28.81%
8/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$105.00 ➝ $115.00	+8.12%
7/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $107.00	+11.98%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+15.64%
8/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$88.00 ➝ $90.00	-0.56%
7/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$91.00 ➝ $99.00	+6.29%
6/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+15.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:47 AM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 20, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

Cardinal Health, Inc. reported a quarterly revenue of $52.28 billion, exceeding the consensus estimate of $50.90 billion, indicating strong financial performance and potential for growth.
The company has a current stock price of $120.34, which reflects a recent increase of 1.7%, suggesting positive market sentiment and investor confidence.
Analysts anticipate an earnings per share (EPS) of 7.83 for the current year, indicating expected profitability and potential for dividend growth.
Several brokerages have recently upgraded their price targets for Cardinal Health, Inc., with an average target price of $123.00, suggesting that analysts see value in the stock and expect it to appreciate.
The company maintains a dividend payout ratio of 39.30%, which indicates a commitment to returning value to shareholders while still retaining a significant portion of earnings for reinvestment.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

Cardinal Health, Inc. experienced a 4.3% decline in quarterly revenue compared to the same period last year, which may raise concerns about its growth trajectory and market competitiveness.
The company has a negative return on equity of 56.56%, indicating that it is not generating profit effectively from its equity, which could be a red flag for potential investors.
Insider selling activity has been noted, with an insider selling 16,573 shares, which may signal a lack of confidence in the company's future performance from those closest to it.
Despite recent upgrades, one analyst has rated the stock with a sell rating, suggesting that there are differing opinions on the stock's future performance.
The company has cut its dividend, which could indicate financial strain or a shift in strategy, potentially disappointing income-focused investors.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $123.00, with a high forecast of $139.00 and a low forecast of $101.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 0.95% based on their 12-month stock forecasts.
: Cardinal Health has been rated by research analysts at Argus, Barclays, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, and UBS Group in the past 90 days.
: Analysts like Cardinal Health less than other "medical" companies. The consensus rating for Cardinal Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

War on Elon Escalates… (Ad)

One company holds a near-total monopoly on it.

This page (NYSE:CAH) was last updated on 11/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target